EMA Authorised: Leflunomide medac (leflunomide) — medac Gesellschaft für klinische Spezialpräparate mbH

View source ↗

Summary

Authorised status for Leflunomide medac (leflunomide) intended for rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Leflunomide medac (leflunomide)

Snippet

Status: Authorised. Therapeutic area: Arthritis, Rheumatoid. MAH: medac Gesellschaft für klinische Spezialpräparate mbH. Decision date: 31/07/2026